Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? - PubMed (original) (raw)

Review

Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?

M Prentki et al. Diabetes. 1996 Mar.

Abstract

Widely held theories of the pathogenesis of obesity-associated NIDDM have implicated apparently incompatible events as seminal: 1) insulin resistance in muscle, 2) abnormal secretion of insulin, and 3) increases in intra-abdominal fat. Altered circulating or tissue lipids are characteristic features of obesity and NIDDM. The etiology of these defects is not known. In this perspective, we propose that the same metabolic events, elevated malonyl-CoA and long-chain acyl-CoA (LC-CoA), in various tissues mediate, in part, the pleiotropic alterations characteristic of obesity and NIDDM. We review the evidence in support of the emerging concept that malonyl-CoA and LC-CoA act as metabolic coupling factors in beta-cell signal transduction, linking fuel metabolism to insulin secretion. We suggest that acetyl-CoA carboxylase, which synthesizes malonyl-CoA, a "signal of plenty," and carnitine palmitoyl transferase 1, which is regulated by it, may perform as fuel sensors in the beta-cell, integrating the concentrations of all circulating fuel stimuli in the beta-cell as well as in muscle, liver, and adipose tissue. The target effectors of LC-CoA may include protein kinase C sub-types, complex lipid formation, genes encoding metabolic enzymes or transduction factors, and protein acylation. We support the concept that only under conditions in which both glucose and lipids are plentiful will the metabolic abnormality, which may be termed glucolipoxia, become apparent. If our hypothesis is correct that common signaling abnormalities in the metabolism of malonyl-CoA and LC-CoA contribute to altered insulin release and sensitivity, it offers a novel explanation for the presence of variable combinations of these defects in individuals with differing genetic backgrounds and for the fact that it has been difficult to determine whether one or the other is the primary event.

PubMed Disclaimer

Cited by

Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.
Nolan CJ, Ruderman NB, Kahn SE, Pedersen O, Prentki M. Nolan CJ, et al. Diabetes. 2015 Mar;64(3):673-86. doi: 10.2337/db14-0694. Diabetes. 2015. PMID: 25713189 Free PMC article. Review.
Functional interaction between peroxisome proliferator-activated receptors-alpha and Mef-2C on human carnitine palmitoyltransferase 1beta (CPT1beta) gene activation.
Baldán A, Relat J, Marrero PF, Haro D. Baldán A, et al. Nucleic Acids Res. 2004 Sep 8;32(16):4742-9. doi: 10.1093/nar/gkh806. Print 2004. Nucleic Acids Res. 2004. PMID: 15356291 Free PMC article.
Glucolipotoxicity of the pancreatic beta cell.
Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontés G. Poitout V, et al. Biochim Biophys Acta. 2010 Mar;1801(3):289-98. doi: 10.1016/j.bbalip.2009.08.006. Epub 2009 Aug 26. Biochim Biophys Acta. 2010. PMID: 19715772 Free PMC article. Review.
Glucagon-like peptide-1 prevents beta cell glucolipotoxicity.
Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E, Prentki M. Buteau J, et al. Diabetologia. 2004 May;47(5):806-15. doi: 10.1007/s00125-004-1379-6. Epub 2004 Apr 17. Diabetologia. 2004. PMID: 15095038
Minor role of mitochondrial respiration for fatty-acid induced insulin secretion.
Schulz N, Kluth O, Jastroch M, Schürmann A. Schulz N, et al. Int J Mol Sci. 2013 Sep 16;14(9):18989-98. doi: 10.3390/ijms140918989. Int J Mol Sci. 2013. PMID: 24065099 Free PMC article.

Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? - PubMed (original) (raw)